Refractory thrombocytopenia in SLE patient with massive thigh hematoma and hematuria successfully treated with Rituximab: Case Report
Journal Title: International Journal of Clinical Rheumatology - Year 2019, Vol 14, Issue 1
Abstract
Background: Systemic Lupus Erythematosus is a multisystemic inflammatory disease with broad clinical presentation, 9.5% to 44.5% of patients with SLE have thrombocytopenia complication of different grades. No significant increase in risk of hemorrhage was found in patients with SLE with moderate thrombocytopenia, while those with severe thrombocytopenia frequently developed bleeding, which is associated with the activity of the disease and potentially life-threatening condition, if left untreated. Case presentation: We report a case of 35-year-old SLE male patient, presented with sudden painful large non-traumatic ecchymotic lesion on the right thigh extending to calf with macroscopic hematuria. At presentation, platelets count was 50 x 109/L with hemoglobin dropping from 10.3 to 6.9 g/dl. Anticardiolipin antibody and Antiphospholipid antibody were absent. Other factors including infection and visceral involvement were excluded. MRI of the thigh showed huge intramuscular hematoma extending to calf. Satisfactory control was partially achieved with platelet transfusion, pulse steroid, cellcept, IVIG (intravenous immunoglobulins) and consequently Rituximab. Our case describes refractory thrombocytopenia not responding to multiple agents including high dose steroids, cellcept, platelet transfusion, IVIG (intravenous immunoglobulins) and cyklokapron; however, it achieved its complete remission with Rituximab. Bleeding is not usual presentation with moderate thrombocytopenia in SLE patients and presumably played a role in prognosis. Conclusion: Our case report has demonstrated the efficacy of treating refractory thrombocytopenia resistant to steroids due to Systemic Lupus Erythematosus in whom other reasonable options have been exhausted.
Authors and Affiliations
Maha J Aljasser, Hanady Manasfi, Amjad Abdelnabi, Hanan Y Abdurabu
Keywords
Related Articles
- EP ID EP614572
- DOI -
- Views 37
- Downloads 0
Improved clinical outcomes and physical activity in patients with rheumatoid arthritis treated with originator adalimumab in routine clinical practice
Background/Objective: We aimed at evaluating changes in habitual physical activity, disease activity and physical function following treatment with originator adalimumab (ADAORIG) in patients with Rheumatoid Arthritis (R...
Clinical and epidemiological characterization of psoriasis and psoriatic arthritis in a multidisciplinary assessment model
Background: Presentation and clinical course in Psoriasis are heterogeneous. A multidisciplinary assessment model was designed, under a procedure manual for five specialties related to disease manifestations: dermatology...
Awareness on dietary restriction in case of gout
Gout is a rheumatologically oriented metabolic disease usually occurs due to rise in uric acid in the blood by altering dietary intake. We know gout affects about 1% to 2% of the Western population at some point in their...
Effect of curcuma xanthorrhiza suplementation in vitamin D3 administration towards proteinuria, serum anti-dsDNA and IL-17 levels on systemic lupus erythematosus (sle) patients with hypovitamin D
Background: Vitamin D is an immunomodulator that plays a role in immunoregulation. Curcumin is also a potential immunomodulator in several autoimmune diseases. Curcumin-vitamin D bonds in VDR have different positions, th...
Predictive value of rheumatoid factor titre in cryoglobulinemia in Hepatitis C positive patients
Background/objective: HCV viremia has been known to provoke a plethora of autoimmune syndromes as well as nonspecific rheumatologic manifestations. HCV is the most frequent cause of mixed cryoglobulinemia, which is chara...